{"cdcTestId":"2022-0080","testcaseName":"Patient has been administered the first dose as AstraZeneca, second dose as Sinovac Covid-19 and third dose as Moderna Bivalent booster vaccine","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not Recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2001-07-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-07-19T00:00:00","vaccineName":"AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)","cvx":"210","mvx":"ASZ","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-16T00:00:00","vaccineName":"Coronavac (Sinovac) COVID-19 Vaccine","cvx":"511","mvx":"SNV","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-16T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"229","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-07-19T00:00:00","vaccineName":"AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)","cvx":"210","mvx":"ASZ","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-16T00:00:00","vaccineName":"Coronavac (Sinovac) COVID-19 Vaccine","cvx":"511","mvx":"SNV","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-16T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"229","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-09-27T12:13:12.31","generalDescription":"This test case describes when a patient is administered a first dose of  the Covid-19 vaccine as AstraZeneca and a second dose of the Covid-19 vaccine as Sinovac that both doses are valid.  A booster (bivalent preferred) dose should be forecast in 8 weeks.","changedInVersion":"4.27","reasonForChange":""}